Principal
Current• Currently Vice President, Regenerative Medicine, Zen Bio Inc.• Serve as Chief Scientific Officer of Brite Bio Inc., a biotechnology company founded in 2012.
Please complete the CAPTCHA to continue
@earthlink.net
✓
3 phones found area 919
✓
LinkedIn matched
A concise factual answer block for searchers comparing this professional profile.
John Ludlow is listed as Principal at JWLudlow Consulting, LLC, based in Raleigh, North Carolina, United States. AeroLeads shows a work email signal at earthlink.net, phone signal with area code 919, and a matched LinkedIn profile for John Ludlow.
John Ludlow previously worked as Senior Director at Tengion and Senior Director at Vesta Therapeutics. John Ludlow holds Ph.D, Microbiology from Kansas State University.
This section adds company-level context without repeating John Ludlow's masked contact details.
AeroLeads found 1 current-domain work email signal for John Ludlow. Compare company email patterns before reaching out.
Principal, JWLudlow Consulting, LLCChapel Hill, NC 2012-presentSpecializing in :• Life sciences start-ups• Product and assay development• Bioprocess research• Cell therapeutics• Tissue engineering • Regenerative medicineSenior Director, Process Research and Assay DevelopmentTengion Inc., Winston-Salem, NC 2005 – 2012Increasing responsibilities during a period of rapid growth including:• Developing and managing a research and clinical development program for tissue engineered products• Hiring and managing 8 laboratory personnel• Evaluating emerging technologies in the areas of tissue engineering• Initiating clinical trial sites • Directing research and implementation of organogenesis for future product development• Directing transition from research laboratories to early manufacturing and development stages• Working closely with regulatory agencies to ensure approval of the company's productsSelected Achievements:• Involved in laboratory building from the blueprints to fully functioning facility and staff• Inventor on six filed patent applications • One patent awarded August 2008• CMC sub-section writing for IND of a Phase II clinical trial of bladder augment product; allowance granted in December 2007• CMC sub-section writing for IND of a Phase II clinical trial of neo-conduit product; allowance granted in December 2010• Contributed to the development of GLP and GMP compliant processes for two tissue engineered products• Ensure full compliance with Federal, State, and Local regulatory guidelines in all business operations• Support business development efforts to explore and implement partner relationshipsSpecialties: Key Expertise:• Overseeing all aspects of, and participating at the bench-level in, laboratory-based research and development in oncology, liver cell therapy, bladder tissue engineering, with emphasis in cell biology, virology, molecular biology, and protein biochemistry• Developing GLP and GMP compliant processes for cell and tissue based products• Designing and executing qualification and validation studies• Technical writing and editing• Project Management
Listed skills include Molecular Biology, Virology, Biochemistry, Technical Writing, and 46 others.
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
Chapel Hill, Nc
• Currently Vice President, Regenerative Medicine, Zen Bio Inc.• Serve as Chief Scientific Officer of Brite Bio Inc., a biotechnology company founded in 2012.
A dedicated, supportive and decisive leader with demonstrated accomplishments in managing and directing process area-specific research and clinical product development. A team player who oversees all aspects of, and participates at the bench level in, laboratory-based research and process development for Tengion, Inc., a tissue engineering company. Responsibilities include bringing new products into bioprocessing research and development, taking new products to demonstration in animal studies, GLP and non-GLP production of neo-organs, initiation of clinical trial sites.
Increasing responsibilities during a period of rapid growth including:• Developing and managing a research and clinical development program for liver-based cell therapy• Hiring and managing 5 laboratory personnel• Developing and managing research and clinical development budgets of $500K to $1M• Managing research projects for contract and academic laboratories • Developing commercial avenues to generate revenue• Evaluating emerging technologies in the areas of oncology and stem cell differentiation• Site visiting cGMP manufacturing facilities• Published 3 manuscripts on this research
Selected Achievements:• Built a laboratory from the blueprints to fully functioning facility and staff• Developed a proprietary process for the manufacture of liver cell therapy products• Inventor on two filed patent applications • CMC section writing for Phase I clinical trial of liver cell therapy product IND; allowance granted in July 2002• Contributed towards discovery of specific marker for adult liver-derived hepatic stem/progenitor cells• Generated revenue by providing liver cells to other commercial and academic researchers
Taught an advanced undergraduate class in genetics, including the laboratory
Developed and managed an independently-funded research and development program focusing on tumor suppressor activity and cell cycle regulatory protein structure and function.Selected Achievements:• Constructed molecular and biological reagents to investigate regulation of cell cycle regulatory proteins including cyclin-dependent kinases, protein phosphatases, and protein phosphatase inhibitors• Developed an inducible expression system in cancer cells to characterize serine/threonine protein phosphatase function• Isolated and identified a unique, naturally-occurring bioreactive protein with demonstrated ability to enhance ovarian cancer cell sensitivity to Taxol• Characterized the effect of hypoxia on ovarian cancer cell growth at the molecular level• Published 44 manuscripts and books on this research • Awarded 18 independent investigator-initiated research grants totaling $1.5M• Trained 4 graduate students to successful completion of requirements for Ph.D. degree• Awarded Outstanding Graduate Educator by medical school students• Trained 1 postdoctoral fellow and 14 undergraduate students in oncology and biochemistry
Ph.D. in Microbiology, Virology focus Kansas State University, Manhattan, Kansas • Defined differences in biological activity.
Research focused on developing an enzyme-linked immunosorbent assay for the detection of infectious pancreatic necrosis (IPNV) in trout.
Quick answers generated from the profile data available on this page.
John Ludlow works for JWLudlow Consulting, LLC.
John Ludlow is listed as Principal at JWLudlow Consulting, LLC.
AeroLeads has found 1 work email signal at @earthlink.net for John Ludlow at JWLudlow Consulting, LLC.
AeroLeads has found 3 phone signal(s) with area code 919 for John Ludlow at JWLudlow Consulting, LLC.
John Ludlow is based in Raleigh, North Carolina, United States while working with JWLudlow Consulting, LLC.
John Ludlow has worked for Jwludlow Consulting, Llc, Tengion, Vesta Therapeutics, Incara Pharmaceuticals, and Rochester Institute Of Technology.
You can use AeroLeads to view verified contact signals for John Ludlow at JWLudlow Consulting, LLC, including work email, phone, and LinkedIn data when available.
John Ludlow holds Ph.D, Microbiology from Kansas State University.
John Ludlow is listed with skills including Molecular Biology, Virology, Biochemistry, Technical Writing, Cell Biology, Tissue Engineering, Cell Based Assays, and Biotechnology.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contactsCheck these profiles if this is not the John Ludlow you were looking for.